Form 6-K PSYENCE BIOMEDICAL LTD. For: Nov 21

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2025

 

Commission File Number: 001-41937

 

Psyence Biomedical Ltd.

(Translation of registrant’s name into English)

 

121 Richmond Street West
Penthouse Suite 1300
Toronto, Ontario M5H 2K1

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

☒ Form 20-F      ☐ Form 40-F 

 

 

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Press Release, dated November 12, 2025

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: November 21, 2025

 

Psyence Biomedical Ltd.
By:	/s/ Warwick Corden-Lloyd
Name:	Warwick Corden-Lloyd
Title:	Chief Financial Officer

 

ATTACHMENTS / EXHIBITS

PRESS RELEASE, DATED NOVEMBER 12, 2025

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote
• Cannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing Agreement
• Mkango Resources Limited Announces HyProMag USA Advances Texas Hub & Magnet Platform